Tag: Neffy™ (ARS-1)
Clinical Data Supporting neffy® Epinephrine Nasal Spray Presented at Scientific Meeting
Data builds the case for prompt FDA approval.
How the FDA Has Continually Failed the Food Allergy Community and...
We must take action if we truly want to have needle-free options approved in the future.
Take Action: The FDA MUST Approve Nasal Epinephrine
We need your participation to convince the FDA to act.
ARS Responds to FDA’s Request for Additional Study Before Approving neffy...
FDA Issues Complete Response Letter for neffy® New Drug Application with Request for Additional Study.
FDA Denies Approval of Needle-Free Alternative to Epinephrine Auto-injectors
The rejection was unexpected based on feedback from the FDA's expert panel in June.
FDA Delays Approval of neffy™ Intranasal Epinephrine Until September
The expected approval date has been delayed from mid-year.
Viatris, Seller of EpiPen®, Petitions FDA to Delay Approval of neffy™...
A ploy to delay introduction of neffy.
FDA Panel Supports Approval of neffy® Epinephrine Nasal Spray
The first needle-free emergency epinephrine alternative is on the verge of FDA approval.
Hoping Needle-Free Intranasal Epinephrine will be Approved? Tell the FDA!
Your testimony is important and there are two ways you can participate.
